This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Koninklijke Philips' CEO Discusses Q1 2012 Results - Earnings Call Transcript

In the post-Summit survey which we typically do, 99% of the respondents confirm that they have clarity on what they need to do to accelerate performance of their respective businesses. In order to check that the Accelerate! program is in fact cascading down the organization, we also run surveys among 4,000 employees every quarter and the scores indicate that good progress is being made. Details related to this progress are disclosed in the Q1 information deck. At the same time, I want to emphasize that Accelerate! is a multiyear program and much remains to be done to unlock our full potential.

Let’s now discuss the changes in the Executive Committee of Philips. As we previously announced in March, we appointed Eric Rondolat as Chief Executive Officer of Lighting and a Member of the Executive Committee of Philips. Eric has an impressive international career, covering both mature and growth geographies. Most recently, Asia-Pacific and based in China. Eric brings a wealth of experience from the energy management solutions industry. We are confident that he will be able to lead Philips through the industry transformation and emerges the winner in energy efficient LED-based lighting solutions. I am also pleased that in Deborah DiSanzo, we have a worthy successor to Steve Rusckowski. Actually, I’d like to reiterate that I wish Steve well in his future endeavors and I’m thankful to him. Deborah will takeover as the new CEO of Healthcare and also join the Executive Committee of Philips. With Deborah, we have found a strong leader for Healthcare within our own organization. She has a proven track record in the Healthcare industry and has grown the Patient Care & Clinical Informatics, the PCCI business, to become the global market leader in patient monitoring. I am sure that she will be a catalyst in accelerating our Healthcare business.

Read the rest of this transcript for free on

4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 -0.41%
FB $117.81 -0.21%
GOOG $701.43 0.82%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs